Profilo
William G.
Rice was the founder of Achillion Pharmaceuticals, Inc., founded in 1998, where the titles held included President, Chief Executive Officer & Director from 1998 to 2003.
The current job is Chairman at Cylene Pharmaceuticals, Inc. since 2013.
Former jobs include Chairman, President & Chief Executive Officer at Aptose Biosciences, Inc. from 2013 to 2022; Independent Director at Oncolytics Biotech, Inc. from 2015 to 2021; Member-Pediatric Hematology & Oncology at Emory University School of Medicine from 1989 to 1992; and Senior Scientist & Head-Drug Mechanism Lab at Frederick National Laboratory For Cancer Research from 1992 to 1998.
Education includes a doctorate from Emory University, conferred in 1986.
Posizioni attive di William Rice
| Società | Posizione | Inizio |
|---|---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Presidente | 28/09/2010 |
Precedenti posizioni note di William Rice
| Società | Posizione | Fine |
|---|---|---|
| APTOSE BIOSCIENCES INC. | Amministratore Delegato | 30/06/2026 |
| ONCOLYTICS BIOTECH INC. | Direttore/Membro del Consiglio | 01/01/2021 |
| ACHILLION PHARMACEUTICALS, INC. | Fondatore | 01/08/2003 |
Frederick National Laboratory For Cancer Research
Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology Frederick National Laboratory for Cancer Research operates as a federally funded biomedical research institution dedicated to advancing understanding and treatment of cancer, AIDS, and infectious diseases. Frederick National Laboratory provides technical services such as HIV/SIV testing, HPV genotyping, antibody characterization, and nanomedicine studies, and offers training and educational modules to enhance research capacity. The company is based in Frederick. The laboratory offers specialized research programs and cores in areas such as basic science, cancer research technology, vaccine and immunity, molecular immunology, retroviral pathogenesis, bioinformatics, computational science, and clinical research. It integrates fundamental, translational, and clinical research with advanced technological capabilities including molecular diagnostics, nanotechnology characterization, cryo-electron microscopy, and multi-modality small animal imaging. The laboratory supports innovation through initiatives like the RAS Initiative and the Center for Innovation and Strategic Partnerships, fostering technology development, patents, and collaborations. Its bioinformatics directorate leverages artificial intelligence, machine learning, and advanced computing to analyze genomics, proteomics, and imaging data, supporting nationwide biomedical research efforts. The American company is ultimately controlled by the Government of the United States of America. | Corporate Officer/Principal | 01/01/1998 |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1992 |
Formazione di William Rice
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Aptose Biosciences, Inc.
Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frederick National Laboratory For Cancer Research
Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology Frederick National Laboratory for Cancer Research operates as a federally funded biomedical research institution dedicated to advancing understanding and treatment of cancer, AIDS, and infectious diseases. Frederick National Laboratory provides technical services such as HIV/SIV testing, HPV genotyping, antibody characterization, and nanomedicine studies, and offers training and educational modules to enhance research capacity. The company is based in Frederick. The laboratory offers specialized research programs and cores in areas such as basic science, cancer research technology, vaccine and immunity, molecular immunology, retroviral pathogenesis, bioinformatics, computational science, and clinical research. It integrates fundamental, translational, and clinical research with advanced technological capabilities including molecular diagnostics, nanotechnology characterization, cryo-electron microscopy, and multi-modality small animal imaging. The laboratory supports innovation through initiatives like the RAS Initiative and the Center for Innovation and Strategic Partnerships, fostering technology development, patents, and collaborations. Its bioinformatics directorate leverages artificial intelligence, machine learning, and advanced computing to analyze genomics, proteomics, and imaging data, supporting nationwide biomedical research efforts. The American company is ultimately controlled by the Government of the United States of America. | Electronic Technology |
















